Who am I?

My name is Kabir Nigam. I am a Harvard-trained psychiatrist with expertise in treating patients with trauma and mood disorders. I am currently an attending psychiatrist at Mclean Hospital on an inpatient unit specializing in the treatment of PTSD and other trauma-spectrum disorders. I work within a psychodynamic framework while employing principles rooted in psychoanalysis, internal family systems, acceptance and commitment therapy, and somatic experiencing. I have a special interest in the application of psychedelics and other non-ordinary states of consciousness in psychological healing, and incorporate principles from this into my approach to working with patients.

In addition to my formal education, I have spent my life studying Eastern philosophy and spirituality as a means of understanding and integrating healing paths outside of the Western medical model.

I am here to walk alongside you in this wonderful journey of self-discovery and healing. I wish to help you discover where your path leads, and to help you answer this question for yourself.

Current Positions

Attending Psychiatrist - Mclean Hospital Trauma and Dissociative Disorders Unit

Instructor - Harvard Medical School

Study Therapist - Psilocybin for Opioid-Refractory Pain (Dana Farber Cancer Institute, Yvan Beaussant), Psilocybin for SUD (Brigham and Women’s Hospital, Joji Suzuki)

Education

Resident in Psychiatry - Brigham and Women’s Hospital/Harvard Medical School

  • Chief Resident of Brigham and Women’s Faulkner Hospital (BWFH)

  • Co-Director of BWFH ketamine-assisted psychotherapy program

  • 2024 Resident Teaching Award Recipient

Fellowship in Psychoanalysis - Boston Psychoanalytic Society and Institute

Certificate in Psychedelic-Assisted Therapy - California Institute for Integral Studies

Certificate in MDMA-Assisted Psychotherapy - Multidisciplinary Association for Psychedelic Science

Doctor of Medicine - Virginia Commonwealth University

Master of Research - Imperial College London

  • Neuropsychopharmacology

Bachelor of Science - University of California Los Angeles

  • Neuroscience

Publications

Shen M, Campbell D, Kopczynski A, Maddams S, Rosenblum N, Nigam K, Suzuki J. (2025) Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review. Frontiers in Psychiatry.

Schipper S, Nigam K, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C. (2024) Psychedelic/entactogen‐assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care. Cochrane Library.

Nigam K, King IV F, Espi-Forcen F. (2024) Advancing ketamine in the treatment hierarchy for refractory depression British Journal of Psychiatry.

Nigam K, King IV F, Espi-Forcen F (2024) Ketamine for refractory depression: save the best for last? Journal of Psychopharmacology.

Bouchet L, Sager Z, Yrondi A, Nigam K, Anderson B, Ross S, Petridis P, Beaussant Y (2024) Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review. Journal of Psychopharmacology.

Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guerin B, Thambi P, Tulsky J, Agrawal M. (2023) Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis. Cancer.

Nigam K, Curseen K, Beaussant Y. (2023) Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care. Clinics of Geriatric Medicine.

Ljuslin M, Nigam K, Sholevar R, Rinaldi A, Schipper S, Cloutier A, Sanders J, King IV F, Beaussant Y. (2022) Psychedelic-Assisted Therapies in Patients with Serious Illness: Opportunities and Challenges. Psychiatric Annals.

Beaussant Y, Nigam K. (2022) Expanding Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging. The American Journal of Geriatric Psychiatry.

Nigam K, Pandurangi AK. (2021) Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature. SN Comprehensive Clinical Medicine.

Presentations

Acceptability of Group-Based Psilocybin-Assisted Therapy in Patients with Cancer and Major Depressive Disorder. (2023) American Psychiatric Association Annual. San Francisco, CA. 

Psychedelic-Assisted Therapy in Serious Illness. (2025) Harvard South Shore Psychiatry Residency Didactics. Boston, MA. 

Introduction to Ketamine in Psychiatry. (2024) Brigham and Women’s Hospital Outpatient Psychiatry Case Conference. Boston, MA. 

Psilocybin-Assisted Therapy for Demoralization in Hospice. (2024) Brigham and Women’s Hospital Scholarly Research Series. Boston, MA.

Belief Systems within Psychiatry. (2023) Brigham and Women’s Hospital Resident Education Day. Boston, MA.

Psychedelic-Assisted Therapy: Core Principals and Concepts. (2023) Suffolk University Department of Psychology. Boston, MA.

Culture-Bound Syndromes. (2022) Brigham and Women’s Hospital Resident Education Day. Boston, MA.

Psychedelic-Assisted Therapy and Acceptance and Commitment Therapy. (2022) Mclean Hospital. Boston, MA

Psychedelic-Assisted Therapy in Palliative Care. (2021) Brigham and Women’s Hospital Resident Education Day. Boston, MA.